News

Vaccine MVA-BN shows consistent, robust immunogenicity and safety results

By 33 views
0

A phase III clinical trial showed consistent immunogenicity for a freeze-dried formulation of Bavarian Nordic’s Modified Vaccinia Ankara.

Laos malaria outbreak in 2020–21 likely caused by multidrug-resistant strains of P. falciparum

Previous article

Eating ultra-processed foods increases risk of cognitive decline

Next article

You may also like

Comments

Leave a reply

Your email address will not be published. Required fields are marked *

More in News